comparemela.com

Latest Breaking News On - Bharat biotech international ltd - Page 21 : comparemela.com

Bharat Biotech submits data on COVID-19 trial data of Covaxin in children

Bharat Biotech submitted data of the Phase 2/3 trials of COVID-19 vaccine Covaxin for use in children under 18 years of ageto the Central Drugs Standard Control Organisation.

WHO further delays Covaxin clearance over technical queries

WHO further delays Covaxin clearance over technical queries
indiatvnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatvnews.com Daily Mail and Mail on Sunday newspapers.

Bharat Biotech Finishes Phase 2 Vaccine Trials For Kids

Bharat Biotech has successfully completed its trials of Phase 2/3 Covid 19 vaccine, Covaxin for use in children under the age of 18, and is scheduled to submit the data to the DCGI by next week said Krishna Ella, Chairman and Managing Director of Bharat Biotech International Ltd. He told reporters that Covaxin manufacturing will reach 55 million doses in October, up from 35

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.